Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 10 patents granted in the last 365 days
Axcess Global Sciences LLC is currently navigating 4 pending office actions within the Biotechnology & Pharmaceuticals technology area. These 4 actions are distributed among distinct examiners, meaning each examiner is responsible for 1 action. This lack of examiner overlap suggests that the company's current prosecution efforts are not being influenced by an individual's examination history or tendencies.
The portfolio's 4 pending actions are spread across 3 distinct art units, indicating technical variety within the biotechnology sector. HOWELL, THEODORE R is the busiest examiner, though they manage 1 pending office action. Because the actions are split among 3 specialized classifications, the company faces a diverse set of administrative guidelines. The ratio of examiners to art units shows that personnel are working within the same technical classification, providing a point of comparison for prosecution results. This distribution requires the company to adapt to different examination standards across its biotechnology filings.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §102 only | 1 (25%) |
| Double-patenting + other | 1 (25%) |
| Multi-statute (no §101) | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HOWELL, THEODORE R | 1 | 66.8% | +25.3% |
| MCMILLIAN, KARA RENITA | 1 | 30.7% | +37.9% |
| IVANOVA, SVETLANA M | 1 | 50.9% | +51.5% |
| NEAGU, IRINA | 1 | 46.8% | +57.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16551594 | COMPOSITIONS AND METHODS FOR DELIVERING TETRAHYDROCANNABINOL AND KETONE BODIES | NEAGU, IRINA | 63d |
| 19303084 | SOLID R-BETA-HYDROXYBUTYRIC ACID COMPOSITION | MCMILLIAN, KARA RENITA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16551594 | COMPOSITIONS AND METHODS FOR DELIVERING TETRAHYDROCANNABINOL AND KETONE BODIES | NEAGU, IRINA | 63d |
| 19319520 | USE OF S-BETA-HYDROXYBUTYRATE COMPOUNDS TO IMPROVE HEART FUNCTION IN A HUMAN | HOWELL, THEODORE R | — |
| 19303084 | SOLID R-BETA-HYDROXYBUTYRIC ACID COMPOSITION | MCMILLIAN, KARA RENITA | — |
| 18140493 | ADMINISTRATION OF R-BETA-HYDROXYBUTYRATE AND RELATED COMPOUNDS IN VETERINARY APPLICATIONS | IVANOVA, SVETLANA M | — |
| Art Unit | Apps |
|---|---|
| 1628 | 1 |
| 1627 | 1 |
| 1629 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19319520 | USE OF S-BETA-HYDROXYBUTYRATE COMPOUNDS TO IMPROVE HEART FUNCTION IN A HUMAN | HOWELL, THEODORE R | 1628 | §112DP | Non-Final OA | — | Pending | Sep 04, 2025 |
| 19303084 | SOLID R-BETA-HYDROXYBUTYRIC ACID COMPOSITION | MCMILLIAN, KARA RENITA | — | §102§103Other | Non-Final OA | — | Pending | Aug 18, 2025 |
| 18140493 | ADMINISTRATION OF R-BETA-HYDROXYBUTYRATE AND RELATED COMPOUNDS IN VETERINARY APPLICATIONS | IVANOVA, SVETLANA M | 1627 | §102 | Non-Final OA | — | Pending | Apr 27, 2023 |
| 16551594 | COMPOSITIONS AND METHODS FOR DELIVERING TETRAHYDROCANNABINOL AND KETONE BODIES | NEAGU, IRINA | 1629 | §103§112 | Final Rejection | 63d | Pending | Aug 26, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial